InvestorsHub Logo
Followers 291
Posts 11893
Boards Moderated 0
Alias Born 01/24/2012

Re: powerbattles post# 692

Tuesday, 01/31/2017 1:59:28 PM

Tuesday, January 31, 2017 1:59:28 PM

Post# of 732
Found some interesting stuff on QMDT. They signed a licensing deal with a company called VIRIDIS BIOPHARMA PVT. LTD in 2010, and it looks like it's still on-going.

https://www.lawinsider.com/contracts/55sHYLC5gQ0rNazsFvLVdn/quick-med-technologies/florida/2010-07-30

I went to the VIRIDIS BIOPHARMA PVT. website, which is current, and look what I found under their products:

http://viridisbiopharma.com/index.htm

Microfoam™ and Woundguard™

These innovative dressings, available as a polyurethene foam (Microfoam™) or a 12 ply cotton gauze (Woundguard™), prevent bacterial penetration and inhibits growth within wound dressings. They are based on the cutting edge, patented non-leaching antimicrobial NIMBUS® Technology from Quick-Med Technologies, USA, which TIME magazine called one of the ‘10 Best Discoveries of 2006’. NIMBUS® is based on non-toxic, long chain polymers with high charge density that provide superior efficacy via a physical action on microbes. By destroying bacteria at the cellular level, NIMBUS® eliminates the risk of developing drug resistance. The technology is highly effective against a multitude of bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE).


http://viridisbiopharma.com/products/dressings.htm

And found this too:

Quick-Med Technologies

Quick-Med Technologies, Inc is a life sciences company focused on developing proprietary, broad-based technologies for infection prevention and control in the consumer and healthcare markets. They developed the patented NIMBUS® technology which is licensed by Viridis for the manufacture of Microfoam™ and Woundguard™.